INMB · Company research
INmune Bio Inc. Common stock (INMB): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| INmune Bio (INMB) Partners with Quantum Computing to Advance Alz - GuruFocus | INmune Bio (INMB) Partners with Quantum Computing to Advance Alz GuruFocus | View source ↗ | GuruFocus | Oct 14, 2026 | neutral | 0 | 0.6 |
| A quantum-computing company gets its first customer in pharma and biotech: INmune Bio - Stock Titan | A quantum-computing company gets its first customer in pharma and biotech: INmune Bio Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| INmune Bio (INMB) Slips 3.61% to $1.87 as Shares Drift Toward Support at $1.78 - Risk Reward Setups - dars.gov.et | INmune Bio (INMB) Slips 3.61% to $1.87 as Shares Drift Toward Support at $1.78 - Risk Reward Setups dars.gov.et | View source ↗ | dars.gov.et | Oct 7, 2026 | neutral | 0 | 0.6 |
| INmune Bio Inc. (INMB) Stock Price, News, Quote & History - Yahoo! Finance Canada | INmune Bio Inc. (INMB) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Inmune Bio (INMB) gives director 3-year option grant - Stock Titan | Inmune Bio (INMB) gives director 3-year option grant Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| [Form 3] Inmune Bio, Inc. Initial Statement of Beneficial Ownership - Stock Titan | [Form 3] Inmune Bio, Inc. Initial Statement of Beneficial Ownership Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director - Stock Titan | Inmune Bio (NASDAQ: INMB) grants 100,000 stock options to new director Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment (NASDAQ:INMB) - Seeking Alpha | INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment (NASDAQ:INMB) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 28, 2026 | neutral | 0 | 0.6 |
| A rare skin-disease drug seeks orphan status that may bring 10 years of EU exclusivity - Stock Titan | A rare skin-disease drug seeks orphan status that may bring 10 years of EU exclusivity Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| INMB|INmune Bio Inc|Price:1.870|Chg%:-0.070 - TradingKey | INMB|INmune Bio Inc|Price:1.870|Chg%:-0.070 TradingKey | View source ↗ | TradingKey | Jul 26, 2026 | neutral | 0 | 0.6 |
| Is INmune Bio (NASDAQ:INMB) In A Good Position To Invest In Growth? - Simply Wall Street | Is INmune Bio (NASDAQ:INMB) In A Good Position To Invest In Growth? Simply Wall Street | View source ↗ | Simply Wall Street | Jul 1, 2026 | neutral | 0 | 0.6 |
| INMB Forecast — Price Target — Prediction for 2027 - TradingView | INMB Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| INMUNE BIO ($INMB) Releases Q1 2026 Earnings - Quiver Quantitative | INMUNE BIO ($INMB) Releases Q1 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | May 7, 2026 | neutral | 0 | 0.6 |
| INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely - Yahoo Finance | INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely Yahoo Finance | View source ↗ | Yahoo Finance | Apr 1, 2026 | neutral | 0 | 0.6 |
| INMB Stock Gained 3% Today – What Did The FDA Say About Its Alzheimer’s Trial? - Stocktwits | INMB Stock Gained 3% Today – What Did The FDA Say About Its Alzheimer’s Trial? Stocktwits | View source ↗ | Stocktwits | Feb 12, 2026 | neutral | 0 | 0.6 |
| Should I buy INmune Bio (INMB) - Zacks Investment Research | Should I buy INmune Bio (INMB) Zacks Investment Research | View source ↗ | Zacks Investment Research | Nov 6, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.